EMULATE

Company Snapshot

Founded: 1994
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: North America, Europe, Asia-Pacific, Rest of World
Corporate Address: 6455 Weathers Place San Diego, California 92121 U.S. Tel. +1-858-453-0848 www.cellapplications.com

Company Overview

Emulate is a biotechnology company specializing in the commercialization of automated human organs-on-chips platforms. These platforms are designed to expedite drug development, identify toxicities, and promote advancements in personalized medicine. 

EMULATE In Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

BCC Research Market Analyst says global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

BCC Research Market Report for Laboratory Animal Models, 3D Cultures and Organoids Market. Global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a CAGR of...

Company's Business Segments

  • Products : Organ Chip Overview, Brain Chip, Colon Intestine Chip, Duodenum Intestine Chip, Kidney Chip, Liver Chip, Lung Chip, Platform, Consumables, BioKits, Software.
  • Services : Standard Services, Custom Services, Meet the Team, Contact Research Services.

Applications/End User Industries

  • Healthcare
  • Cells Diagnostics
  • Life Sciences
  • Reagents Industries